cardiology careers collections past issues search home
     

J Am Coll Cardiol, 1993; 22:95-98
© 1993 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perry, J.
Right arrow Articles by Friedman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perry, J.
Right arrow Articles by Friedman, R.

Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults

JC Perry, TK Knilans, D Marlow, SW Denfield, AL Fenrich, and RA Friedman

Baylor College of Medicine, Texas Children's Hospital, Houston.

OBJECTIVES. The purpose of this study was to evaluate the efficacy of intravenous amiodarone in young patients. BACKGROUND. Oral amiodarone therapy has proved useful for problematic arrhythmias in children, but its pharmacokinetics with the oral route preclude its use in several acute settings. METHODS. Intravenous amiodarone was administered in 1-mg/kg body weight aliquots followed by continuous infusion to patients with potentially life-threatening tachyarrhythmias that had not been abolished by standard therapies. RESULTS. Ten patients (mean age 6.8 years) received intravenous amiodarone: for ventricular tachycardia in seven patients and for atrial tachycardia, junctional tachycardia and multiple arrhythmias in one patient each. Surgery for congenital heart defects had been performed previously in six patients. Two patients had a hamartoma causing ventricular tachycardia. Six of 10 patients had complete resolution of arrhythmia with intravenous amiodarone: 4 of 7 with ventricular tachycardia, 1 of 1 with atrial tachycardia and 1 of 1 with postoperative junctional ectopic tachycardia. Intravenous amiodarone was not successful in the two patients with a hamartoma but slowed ventricular tachycardia in one, allowing successful surgical cure. Average drug load at the time of effect was 4.8 mg/kg body weight. Four patients had transient hypotension during loading, corrected with volume or low dose calcium. Intravenous infusion of amiodarone, 10 mg/kg per day, continued an average of 3 days. Four of 10 patients died, all of nonarrhythmic causes not attributable to intravenous amiodarone. CONCLUSIONS. Intravenous amiodarone was well tolerated in this small series of patients. Postoperative ventricular tachycardia was responsive to intravenous amiodarone in 80% (8 of 10) of the patients (95% confidence interval 40% to 99%). Use of this drug in acute, postoperative tachyarrhythmias may be lifesaving in some patients when standard intravenous therapies fail.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. A. Haas and C. K. Camphausen
Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia.
J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1215 - 1222.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
American Heart Association
2005 American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) of Pediatric and Neonatal Patients: Pediatric Advanced Life Support
Pediatrics, May 1, 2006; 117(5): e1005 - e1028.
[Full Text] [PDF]


Home page
PediatricsHome page
The International Liaison Committee on Resuscitati
The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science With Treatment Recommendations for Pediatric and Neonatal Patients: Pediatric Basic and Advanced Life Support
Pediatrics, May 1, 2006; 117(5): e955 - e977.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 12: Pediatric Advanced Life Support
Circulation, December 13, 2005; 112(24_suppl): IV-167 - IV-187.
[Full Text] [PDF]


Home page
CirculationHome page
J. P. Saul, W. A. Scott, S. Brown, P. Marantz, V. Acevedo, S. P. Etheridge, J. C. Perry, J. K. Triedman, S. W. Burriss, P. Cargo, et al.
Intravenous Amiodarone for Incessant Tachyarrhythmias in Children: A Randomized, Double-Blind, Antiarrhythmic Drug Trial
Circulation, November 29, 2005; 112(22): 3470 - 3477.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 6: Pediatric Basic and Advanced Life Support
Circulation, November 29, 2005; 112(22_suppl): III-73 - III-90.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
A. Thompson and J. R. Balser
Perioperative cardiac arrhythmias
Br. J. Anaesth., July 1, 2004; 93(1): 86 - 94.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Bronzetti, R. Formigari, A. Giardini, G. Frascaroli, G. Gargiulo, and F. M. Picchio
Intravenous flecainide for the treatment of junctional ectopic tachycardia after surgery for congenital heart disease
Ann. Thorac. Surg., July 1, 2003; 76(1): 148 - 151.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Bando
Invited commentary
Ann. Thorac. Surg., July 1, 2003; 76(1): 151 - 151.
[Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
M. Botero and L. K. Davies
Diagnosis and Management of Arrhythmias in Children After Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2001; 5(1): 122 - 133.
[Abstract] [PDF]



 
  cardiology careers collections past issues search home